Table 2 Baseline CMR characteristics of DCM patients with and without T2DM
| Â | All patients | With T2DM | No T2DM | P value |
|---|---|---|---|---|
(n = 1152) | (n = 155) | (n = 997) |  | |
LVEDV (ml) | 289 ± 100 | 297 ± 109 | 288 ± 98 | 0.35 |
LVESV (ml) | 220 ± 99 | 233 ± 103 | 218 ± 98 | 0.08 |
LVEDV index (ml/m2) | 171 ± 58 | 175 ± 63 | 171 ± 57 | 0.38 |
LVESV index (ml/m2) | 130 ± 58 | 139 ± 60 | 129 ± 57 | 0.08 |
LVM (g) | 143 ± 52 | 149 ± 50 | 142 ± 52 | 0.16 |
LVM index (g/m2) | 84 ± 27 | 87 ± 28 | 84 ± 27 | 0.18 |
LVEF (%) | 26 ± 12 | 23 ± 10 | 27 ± 12 | < 0.001 |
RVEDV index (ml/m2) | 99 ± 39 | 97 ± 37 | 100 ± 39 | 0.44 |
RVESV index (ml/m2) | 65 ± 38 | 65 ± 35 | 65 ± 38 | 0.83 |
RVEF (%) | 38 ± 15 | 36 ± 14 | 38 ± 15 | 0.05 |
LGE presence, n | 534 (46%) | 86 (56%) | 448 (45%) | 0.01 |
Native T1 (ms) | 1308 ± 74 | 1323 ± 81 | 1305 ± 73 | 0.01 |
Post T1 (ms) | 470 ± 71 | 445 ± 70 | 474 ± 70 | < 0.001 |
ECV (%) | 31.6 ± 6.0 | 32.7 ± 6.3 | 31.3 ± 5.9 | 0.01 |